Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.28% | 17.09% | -3.29% | -6.24% | -2.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.28% | 17.09% | -3.57% | -6.52% | -2.37% |
| Cost of Revenue | -4.45% | -4.60% | -6.92% | -9.76% | 3.90% |
| Gross Profit | 67.18% | 66.90% | 2.16% | -0.97% | -14.26% |
| SG&A Expenses | -13.83% | -13.96% | 8.82% | 5.49% | -4.54% |
| Depreciation & Amortization | -18.88% | -19.03% | -28.57% | -30.79% | -7.46% |
| Other Operating Expenses | -93.76% | -93.72% | -168.48% | -166.40% | 139.51% |
| Total Operating Expenses | -12.30% | -12.45% | -7.55% | -10.38% | 1.30% |
| Operating Income | 77.51% | 77.54% | 21.47% | 23.87% | -10.45% |
| Income Before Tax | 63.33% | 63.39% | -15.93% | -12.39% | -3.78% |
| Income Tax Expenses | -- | -- | 84.99% | 85.45% | -- |
| Earnings from Continuing Operations | 63.33% | 63.39% | -334.46% | -327.31% | -3.73% |
| Earnings from Discontinued Operations | 28.54% | 28.72% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.62% | 61.68% | -334.46% | -327.31% | -9.10% |
| EBIT | 77.51% | 77.54% | 21.47% | 23.87% | -10.45% |
| EBITDA | 89.14% | 89.16% | 33.11% | 35.15% | -14.90% |
| EPS Basic | 80.00% | 79.55% | -250.00% | -242.11% | 38.36% |
| Normalized Basic EPS | 83.33% | 86.67% | 40.74% | 42.86% | 33.33% |
| EPS Diluted | 80.00% | 79.55% | -250.00% | -242.11% | 38.36% |
| Normalized Diluted EPS | 83.33% | 86.67% | 40.74% | 42.86% | 33.33% |
| Average Basic Shares Outstanding | 86.35% | 86.35% | 57.44% | 57.44% | 78.10% |
| Average Diluted Shares Outstanding | 86.35% | 86.35% | 57.44% | 57.44% | 78.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |